Lisa A. Hammond
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 5%
- Co-authors
- Eric K. RowinskyAnthony W. TolcherChris H. TakimotoDaniel D. Von HoffManuel HidalgoGary M. ClarkDaniel D. KarpP. Santabárbara
- Topics
- Cancer therapeutics and mechanisms (15 papers)Cancer Treatment and Pharmacology (15 papers)HER2/EGFR in Cancer Research (11 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Lisa A. Hammond
56 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 3.0k
- Pulmonary and Respiratory Medicine 2.0k
- Molecular Biology 1.6k
- Radiology, Nuclear Medicine and Imaging 457
- Cancer Research 439
Countries citing papers authored by Lisa A. Hammond
This map shows the geographic impact of Lisa A. Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa A. Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa A. Hammond more than expected).
Fields of papers citing papers by Lisa A. Hammond
This network shows the impact of papers produced by Lisa A. Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa A. Hammond. The network helps show where Lisa A. Hammond may publish in the future.
Co-authorship network of co-authors of Lisa A. Hammond
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa A. Hammond. A scholar is included among the top collaborators of Lisa A. Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa A. Hammond. Lisa A. Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 8 | |
| 3 | 54 | |
| 4 | 18 | |
| 5 | 25 | |
| 6 | 34 | |
| 7 | 32 | |
| 8 | 59 | |
| 9 | 9 | |
| 10 | A Phase I and pharmacokinetic study of squalamine, an aminosterol angiogenesis inhibitor. | 36 |
| 11 | A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies. | 14 |
| 12 | Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients. | 104 |
| 13 | 50 | |
| 14 | A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. | 112 |
| 15 | 16 | |
| 16 | 25 | |
| 17 | 33 | |
| 18 | 37 | |
| 19 | 55 | |
| 20 | Deciding about leg-lengthening. | 1 |
About Lisa A. Hammond
Lisa A. Hammond is a scholar working on Oncology, Research and Theory and Genetics, having authored 56 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (15 papers) and HER2/EGFR in Cancer Research (11 papers). The work is most often cited by research in Oncology (3.0k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Genetics (344 citations). Lisa A. Hammond has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Eric K. Rowinsky, Anthony W. Tolcher, Chris H. Takimoto, Daniel D. Von Hoff, Manuel Hidalgo, Gary M. Clark, Daniel D. Karp, P. Santabárbara, Mark S. Huberman and Abraham Chachoua. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.